The drug delivery devices market size has grown strongly in recent years. It will grow from $95.99 billion in 2025 to $102.15 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, expansion of injectable therapies, growth in hospital-based drug administration, increasing use of infusion devices, advancements in pharmaceutical formulations.
The drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $128.94 billion in 2030 at a compound annual growth rate (CAGR) of 6%. The growth in the forecast period can be attributed to increasing adoption of home-based drug delivery, rising investments in personalized medicine, expansion of biologics and biosimilars, growing demand for connected delivery devices, increasing integration of digital health platforms. Major trends in the forecast period include increasing adoption of smart drug delivery devices, rising use of self-administration injection systems, growing demand for controlled release technologies, expansion of wearable drug delivery platforms, enhanced focus on patient-centric designs.
Rising healthcare expenditure is anticipated to drive the growth of the drug delivery devices market in the coming years. Healthcare spending refers to the total financial resources allocated to health-related services and products, including expenditures on hospitals, physicians, nursing care, prescription medicines, and public health initiatives. Healthcare spending is increasing due to factors such as an aging population, the growing prevalence of chronic diseases, advancements in medical technologies, and escalating costs of healthcare services and pharmaceuticals. Higher healthcare expenditure supports the development of drug delivery devices by enabling greater investment in research, innovation, and the adoption of advanced technologies that enhance treatment effectiveness and patient outcomes. For example, in May 2024, according to the Office for National Statistics, a UK-based government department, healthcare expenditure in the United Kingdom reached approximately $379 billion (£292 billion) in 2023. This represented a 5.6% nominal increase compared with 2022, a notable rise from the 0.9% growth recorded in the previous year. Therefore, increasing healthcare spending is contributing to the growth of the drug delivery devices market.
Leading players operating in the drug delivery devices market are focusing on the development of advanced solutions, such as targeted oral release capsules, to improve treatment efficacy and reduce systemic side effects. Targeted oral release capsules are designed to withstand the acidic conditions of the stomach and release active ingredients accurately in specific regions of the gastrointestinal tract, thereby enhancing bioavailability and localizing therapy. For instance, in September 2024, Evonik, a Germany-based specialty chemicals and life sciences company, introduced its EUDRACAP colon capsules, which are intended for the delivery of sensitive active substances to the ileo-colonic region. These capsules enable the administration of live biotherapeutic products, oral biologics, peptides, proteins, and nucleotides while maintaining their stability through customized EUDRAGIT coatings. The EUDRACAP colon capsules also simplify formulation development with a ready-to-fill design and accelerate time to market by reducing development complexity. This advancement expands Evonik’s EUDRACAP platform and reinforces its system solutions portfolio for advanced oral drug delivery.
In October 2024, Aptar Pharma, a US-based supplier of drug delivery systems and active material science solutions, acquired the device technology assets of SipNose Nasal Delivery Systems for an undisclosed sum. Through this acquisition, Aptar seeks to broaden its intranasal drug delivery portfolio, strengthen its nose-to-brain delivery capabilities, and accelerate innovation in central nervous system therapeutic platforms. SipNose, an Israel-based company, develops intranasal delivery devices for both liquid and dry powder formulations, enabling local, systemic, and direct brain delivery of active ingredients.
Major companies operating in the drug delivery devices market are Becton Dickinson and Company, Baxter International, B. Braun Melsungen AG, Catalent, West Pharmaceutical Services Inc., Gerresheimer AG, Smiths Medical, Elcam Medical, SMC Ltd., Injex, Ypsomed Holding AG, Nemera, H&T Presspart, Syqe Medical, Antares Pharma, Julphar, Teleflex Medical, Kedalion Therapeutics, MediPrint Ophthalmics, Sorrel Medical, Terumo Corporation, Gilero.
North America was the largest region in the drug delivery devices market in 2025. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the drug delivery devices market by increasing costs of imported polymers, electronic components, precision molds, sensors, and infusion system parts used across injectables, inhalers, and implantable devices. Healthcare providers and device manufacturers in North America and Europe are most affected due to reliance on cross-border component sourcing, while Asia-Pacific faces export-related cost pressures. These tariffs are raising device prices and slowing procurement cycles. However, they are also driving localization of device manufacturing, regional supplier development, and innovation in cost-efficient delivery technologies.
The drug delivery devices market research report is one of a series of new reports that provides drug delivery devices market statistics, including drug delivery devices industry global market size, regional shares, competitors with a drug delivery devices market share, detailed drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the drug delivery devices industry. This drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Drug delivery devices are designed to administer specific drugs to targeted areas of the body for disease treatment. These devices find application in various patient care environments, including hospitals, diagnostic centers, clinics, and home care settings.
The primary routes of drug administration through these devices encompass oral drug delivery, injectable drug delivery, topical drug delivery, ocular drug delivery, pulmonary drug delivery, nasal drug delivery, transmucosal drug delivery, and implantable drug delivery. Oral drug delivery involves the administration of a tablet or capsule into the alimentary canal of a human being. Patient care settings where these devices are utilized include hospitals, diagnostic centers, ambulatory surgery centers/clinics, home care settings, and others. The diverse applications of these drug delivery devices span across areas such as cancer, infectious diseases, respiratory diseases, diabetes, cardiovascular diseases, autoimmune diseases, central nervous system disorders, and more.
The drug delivery devices market consists of sales of instruments such as smart pills, inhalers and nebulizers, drug-eluting stents, safety syringes, and transdermal patches. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $128.94 billion in 2030 at a compound annual growth rate (CAGR) of 6%. The growth in the forecast period can be attributed to increasing adoption of home-based drug delivery, rising investments in personalized medicine, expansion of biologics and biosimilars, growing demand for connected delivery devices, increasing integration of digital health platforms. Major trends in the forecast period include increasing adoption of smart drug delivery devices, rising use of self-administration injection systems, growing demand for controlled release technologies, expansion of wearable drug delivery platforms, enhanced focus on patient-centric designs.
Rising healthcare expenditure is anticipated to drive the growth of the drug delivery devices market in the coming years. Healthcare spending refers to the total financial resources allocated to health-related services and products, including expenditures on hospitals, physicians, nursing care, prescription medicines, and public health initiatives. Healthcare spending is increasing due to factors such as an aging population, the growing prevalence of chronic diseases, advancements in medical technologies, and escalating costs of healthcare services and pharmaceuticals. Higher healthcare expenditure supports the development of drug delivery devices by enabling greater investment in research, innovation, and the adoption of advanced technologies that enhance treatment effectiveness and patient outcomes. For example, in May 2024, according to the Office for National Statistics, a UK-based government department, healthcare expenditure in the United Kingdom reached approximately $379 billion (£292 billion) in 2023. This represented a 5.6% nominal increase compared with 2022, a notable rise from the 0.9% growth recorded in the previous year. Therefore, increasing healthcare spending is contributing to the growth of the drug delivery devices market.
Leading players operating in the drug delivery devices market are focusing on the development of advanced solutions, such as targeted oral release capsules, to improve treatment efficacy and reduce systemic side effects. Targeted oral release capsules are designed to withstand the acidic conditions of the stomach and release active ingredients accurately in specific regions of the gastrointestinal tract, thereby enhancing bioavailability and localizing therapy. For instance, in September 2024, Evonik, a Germany-based specialty chemicals and life sciences company, introduced its EUDRACAP colon capsules, which are intended for the delivery of sensitive active substances to the ileo-colonic region. These capsules enable the administration of live biotherapeutic products, oral biologics, peptides, proteins, and nucleotides while maintaining their stability through customized EUDRAGIT coatings. The EUDRACAP colon capsules also simplify formulation development with a ready-to-fill design and accelerate time to market by reducing development complexity. This advancement expands Evonik’s EUDRACAP platform and reinforces its system solutions portfolio for advanced oral drug delivery.
In October 2024, Aptar Pharma, a US-based supplier of drug delivery systems and active material science solutions, acquired the device technology assets of SipNose Nasal Delivery Systems for an undisclosed sum. Through this acquisition, Aptar seeks to broaden its intranasal drug delivery portfolio, strengthen its nose-to-brain delivery capabilities, and accelerate innovation in central nervous system therapeutic platforms. SipNose, an Israel-based company, develops intranasal delivery devices for both liquid and dry powder formulations, enabling local, systemic, and direct brain delivery of active ingredients.
Major companies operating in the drug delivery devices market are Becton Dickinson and Company, Baxter International, B. Braun Melsungen AG, Catalent, West Pharmaceutical Services Inc., Gerresheimer AG, Smiths Medical, Elcam Medical, SMC Ltd., Injex, Ypsomed Holding AG, Nemera, H&T Presspart, Syqe Medical, Antares Pharma, Julphar, Teleflex Medical, Kedalion Therapeutics, MediPrint Ophthalmics, Sorrel Medical, Terumo Corporation, Gilero.
North America was the largest region in the drug delivery devices market in 2025. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the drug delivery devices market by increasing costs of imported polymers, electronic components, precision molds, sensors, and infusion system parts used across injectables, inhalers, and implantable devices. Healthcare providers and device manufacturers in North America and Europe are most affected due to reliance on cross-border component sourcing, while Asia-Pacific faces export-related cost pressures. These tariffs are raising device prices and slowing procurement cycles. However, they are also driving localization of device manufacturing, regional supplier development, and innovation in cost-efficient delivery technologies.
The drug delivery devices market research report is one of a series of new reports that provides drug delivery devices market statistics, including drug delivery devices industry global market size, regional shares, competitors with a drug delivery devices market share, detailed drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the drug delivery devices industry. This drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Drug delivery devices are designed to administer specific drugs to targeted areas of the body for disease treatment. These devices find application in various patient care environments, including hospitals, diagnostic centers, clinics, and home care settings.
The primary routes of drug administration through these devices encompass oral drug delivery, injectable drug delivery, topical drug delivery, ocular drug delivery, pulmonary drug delivery, nasal drug delivery, transmucosal drug delivery, and implantable drug delivery. Oral drug delivery involves the administration of a tablet or capsule into the alimentary canal of a human being. Patient care settings where these devices are utilized include hospitals, diagnostic centers, ambulatory surgery centers/clinics, home care settings, and others. The diverse applications of these drug delivery devices span across areas such as cancer, infectious diseases, respiratory diseases, diabetes, cardiovascular diseases, autoimmune diseases, central nervous system disorders, and more.
The drug delivery devices market consists of sales of instruments such as smart pills, inhalers and nebulizers, drug-eluting stents, safety syringes, and transdermal patches. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Drug Delivery Devices Market Characteristics
3. Drug Delivery Devices Market Supply Chain Analysis
4. Global Drug Delivery Devices Market Trends and Strategies
5. Drug Delivery Devices Market Analysis of End Use Industries
7. Global Drug Delivery Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Drug Delivery Devices Total Addressable Market (TAM) Analysis for the Market
9. Drug Delivery Devices Market Segmentation
10. Drug Delivery Devices Market Regional and Country Analysis
11. Asia-Pacific Drug Delivery Devices Market
12. China Drug Delivery Devices Market
13. India Drug Delivery Devices Market
14. Japan Drug Delivery Devices Market
15. Australia Drug Delivery Devices Market
16. Indonesia Drug Delivery Devices Market
17. South Korea Drug Delivery Devices Market
18. Taiwan Drug Delivery Devices Market
19. South East Asia Drug Delivery Devices Market
20. Western Europe Drug Delivery Devices Market
21. UK Drug Delivery Devices Market
22. Germany Drug Delivery Devices Market
23. France Drug Delivery Devices Market
24. Italy Drug Delivery Devices Market
25. Spain Drug Delivery Devices Market
26. Eastern Europe Drug Delivery Devices Market
27. Russia Drug Delivery Devices Market
28. North America Drug Delivery Devices Market
29. USA Drug Delivery Devices Market
30. Canada Drug Delivery Devices Market
31. South America Drug Delivery Devices Market
32. Brazil Drug Delivery Devices Market
33. Middle East Drug Delivery Devices Market
34. Africa Drug Delivery Devices Market
36. Drug Delivery Devices Market Competitive Landscape and Company Profiles
37. Drug Delivery Devices Market Other Major and Innovative Companies
40. Drug Delivery Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Drug Delivery Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for drug delivery devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug delivery devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Route Of Administration: Oral Drug Delivery; Injectable Drug Delivery; Topical Drug Delivery; Ocular Drug Delivery; Pulmonary Drug Delivery; Nasal Drug Delivery; Transmucosal Drug Delivery; Implantable Drug Delivery2) By Patient Care Setting: Hospitals; Diagnostic Centers; Ambulatory Surgery Centers/Clinics; Home Care Settings; Other Patient Care Settings
3) By Application: Cancer; Infectious Diseases; Respiratory Diseases; Diabetes; Cardiovascular Diseases; Autoimmune Diseases; Central Nervous System Disorders; Other Applications
Subsegments:
1) By Oral Drug Delivery: Tablets and Capsules; Oral Sprays; Oral Liquids; Oral Disintegrating Tablets2) By Injectable Drug Delivery: Syringes (manual and auto-disable); Vials and Cartridges; Pen Injectors; Infusion Pumps
3) By Topical Drug Delivery: Creams and Ointments; Transdermal Patches; Gels and Lotions; Powders
4) By Ocular Drug Delivery: Eye Drops; Ocular Inserts; Contact Lens Drug Delivery Systems
5) By Pulmonary Drug Delivery: Metered-Dose Inhalers (MDIs); Dry Powder Inhalers (DPIs); Nebulizers
6) By Nasal Drug Delivery: Nasal Sprays; Nasal Powders; Nasal Drops
7) By Transmucosal Drug Delivery: Buccal Tablets; Sublingual Tablets; Mucoadhesive Films
8) By Implantable Drug Delivery: Drug-Implantable Devices; Biodegradable Implants; Reservoir-based Implants
Companies Mentioned: Becton Dickinson and Company; Baxter International; B. Braun Melsungen AG; Catalent; West Pharmaceutical Services Inc.; Gerresheimer AG; Smiths Medical; Elcam Medical; SMC Ltd.; Injex; Ypsomed Holding AG; Nemera; H&T Presspart; Syqe Medical; Antares Pharma; Julphar; Teleflex Medical; Kedalion Therapeutics; MediPrint Ophthalmics; Sorrel Medical; Terumo Corporation; Gilero
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Drug Delivery Devices market report include:- Becton Dickinson and Company
- Baxter International
- B. Braun Melsungen AG
- Catalent
- West Pharmaceutical Services Inc.
- Gerresheimer AG
- Smiths Medical
- Elcam Medical
- SMC Ltd.
- Injex
- Ypsomed Holding AG
- Nemera
- H&T Presspart
- Syqe Medical
- Antares Pharma
- Julphar
- Teleflex Medical
- Kedalion Therapeutics
- MediPrint Ophthalmics
- Sorrel Medical
- Terumo Corporation
- Gilero
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 102.15 Billion |
| Forecasted Market Value ( USD | $ 128.94 Billion |
| Compound Annual Growth Rate | 6.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
